MARALIXIBAT-TREATED PATIENTS WITH ALAGILLE SYNDROME DEMONSTRATE IMPROVED EVENT-FREE SURVIVAL IN A NATURAL HISTORY COMPARISON WITH PATIENTS FROM THE GALA DATABASE: APPLICATION OF REAL-WORLD EVIDENCE ANALYTICS.
NASPGHAN 2022 Annual Meeting, 12 - 15 Ekim 2022, ss.211-213, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Sayfa Sayıları: ss.211-213
- İstanbul Üniversitesi Adresli: Evet